BioRestorative Therapies announces notice of allowance for ThermoStem patent
PremiumThe FlyBioRestorative Therapies announces notice of allowance for ThermoStem patent
2M ago
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results
Premium
Press Releases
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results
2M ago
BioRestorative Therapies reports Q1 EPS (33c) vs. ($1.93) last year
Premium
The Fly
BioRestorative Therapies reports Q1 EPS (33c) vs. ($1.93) last year
2M ago
BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
PremiumPress ReleasesBioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
3M ago
BioRestorative Therapies Provides First Quarter 2024 Business Update
Premium
Press Releases
BioRestorative Therapies Provides First Quarter 2024 Business Update
3M ago
BioRestorative develops new therapeutic candidate using ThermoStem platform
Premium
The Fly
BioRestorative develops new therapeutic candidate using ThermoStem platform
4M ago
BioRestorative’s BRTX-100 trial to use sham injection control, says Roth MKM
PremiumThe FlyBioRestorative’s BRTX-100 trial to use sham injection control, says Roth MKM
4M ago
BioRestorative announces FDA clearance of Phase 2 BRTX-100 study protocol
Premium
The Fly
BioRestorative announces FDA clearance of Phase 2 BRTX-100 study protocol
4M ago
BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
Premium
Press Releases
BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100